Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:37 PM
Ignite Modification Date: 2025-12-25 @ 2:27 PM
NCT ID: NCT02981966
Description: None
Frequency Threshold: 5
Time Frame: 4 years
Study: NCT02981966
Study Brief: Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
T2DM Individuals on Dapagliflozin Individuals with type 2 diabetes mellitus - dapagliflozin Dapagliflozin: dapagliflozin, 10mg tablet 0 None 0 13 0 13 View
T2DM Individuals on Placebo Individuals with type 2 diabetes mellitus on placebo Placebo: Placebo for dapagliflozin 0 None 0 7 1 7 View
Normal Glucose Tolerance (NGT) on Dapagliflozin Individuals with normal glucose tolerance - dapagliflozin Dapagliflozin: dapagliflozin, 10mg tablet 0 None 0 8 1 8 View
Normal Glucose Tolerance (NGT) Placebo Individuals with normal glucose tolerance - on placebo Placebo: Placebo for dapagliflozin 0 None 0 4 0 4 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Transcient Syncope NON_SYSTEMATIC_ASSESSMENT General disorders None View